Jameson, A, Fylan, B, Bristow, G et al. (5 more authors) (2022) Pharmacogenomics is the future of prescribing in psychiatry. Pharmaceutical Journal, 309. 7964. ISSN 2053-6186
Abstract
Patients' pharmacogenetic data could be used to improve adherence to antipsychotic medication by increasing the likelihood of therapeutic response and reducing the prevalence of adverse drug reactions.
Metadata
Item Type: | Article |
---|---|
Authors/Creators: |
|
Copyright, Publisher and Additional Information: | This is protected by copyright. All rights reserved. This is an author produced version of an article published in Pharmaceutical Journal. Uploaded in accordance with the publisher's self-archiving policy. |
Dates: |
|
Institution: | The University of Leeds |
Academic Units: | The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Health Sciences (Leeds) > Academic Unit of Psychiatry and Behavioural Sciences (Leeds) |
Depositing User: | Symplectic Publications |
Date Deposited: | 27 Oct 2022 13:07 |
Last Modified: | 27 Oct 2022 13:07 |
Status: | Published |
Publisher: | Royal Pharmaceutical Society |
Identification Number: | 10.1211/pj.2022.1.152215 |
Open Archives Initiative ID (OAI ID): | oai:eprints.whiterose.ac.uk:192139 |